A systematic approach to defining the microrna landscape in metastasis

Cancer Research

Volumn 75, Issue 15, 2015, Pages 3010-3019

  Mudduluru, Giridhar ^a,b   Abba, Mohammed ^a,b   Batliner, Jasmin ^a,b   Patil, Nitin ^a,b   Scharp, Maike ^a,b   Lunavat, Taral R ^a,b   Leupold, Jörg Hendrik ^a,b   Oleksiuk, Olga ^a,b   Juraeva, Dilafruz ^b   Thiele, Wilko ^a,c   Rothley, Melanie ^a,c   Benner, Axel ^b   Ben Neriah, Yinon ^d   Sleeman, Jonathan ^a,c   Allgayer, Heike ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 135B; MICRORNA 200; MICRORNA 210; MICRORNA 218; NERVE CELL ADHESION MOLECULE; PROTEIN FOXN3; PROTEIN SETD2; PROTEIN SIAH1; PROTEIN ZEB2; UNCLASSIFIED DRUG; CADHERIN; CDH2 PROTEIN, HUMAN; CELL CYCLE PROTEIN; FOXN3 PROTEIN, HUMAN; HISTONE LYSINE METHYLTRANSFERASE; HOMEODOMAIN PROTEIN; LEUKOCYTE ANTIGEN; MIRN135 MICRORNA, HUMAN; MIRN210 MICRORNA, HUMAN; MIRN218 MICRORNA, HUMAN; NUCLEAR PROTEIN; REPRESSOR PROTEIN; SET2 PROTEIN, HUMAN; SEVEN IN ABSENTIA PROTEINS; UBIQUITIN PROTEIN LIGASE; ZEB2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER TISSUE; CELL MIGRATION; COLORECTAL CANCER; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; METASTASIS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; TUMOR INVASION; ANIMAL; COLORECTAL TUMOR; FACTUAL DATABASE; GENETICS; NUDE MOUSE; REFERENCE VALUE; REPRODUCIBILITY; SECONDARY;

ANIMALS; ANTIGENS, CD; CADHERINS; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; DATABASES, FACTUAL; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HISTONE-LYSINE N-METHYLTRANSFERASE; HOMEODOMAIN PROTEINS; HUMANS; MICE, NUDE; MICRORNAS; NEOPLASM METASTASIS; NUCLEAR PROTEINS; REFERENCE VALUES; REPRESSOR PROTEINS; REPRODUCIBILITY OF RESULTS; UBIQUITIN-PROTEIN LIGASES;

EID: 84939541380     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-0997     Document Type: Article

References (37)

1. Sporn MB. The war on cancer. Lancet 1996;347:1377-81.
2. Cimpean AM, Ribatti D, Raica M. The chick embryo chorioallantoic membrane as a model to study tumor metastasis. Angiogenesis 2008;11: 311-9.
3. Viney JL. Transgenic and gene knockout mice in cancer research. Cancer Metastasis Rev 1995;14:77-90.
4. Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol 2009;4: 199-227.
5. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012;18:883-91.
6. Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, et al. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol 2011;119:92-101.
7. Mudduluru G, Ceppi P, Kumarswamy R, Scagliotti GV, Papotti M, Allgayer H. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene 2011;30:2888-99.
8. Leupold JH, Yang HS, Colburn NH, Asangani I, Post S, Allgayer H. Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene 2007;26:4550-62.
9. van der Horst EH, Leupold JH, Schubbert R, Ullrich A, Allgayer H. TaqMan-based quantification of invasive cells in the chick embryo metastasis assay. Biotechniques 2004;37:940-2.
10. He L, He X, Lim LP, de SE, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007;447:1130-4.
11. Hwang CI, Matoso A, Corney DC, Flesken-Nikitin A, Korner S, Wang W, et al. Wild-type p53 controls cell motility and invasion by dual regulation of MET expression. Proc Natl Acad Sci U S A 2011;108:14240-5.
12. Liu Z, Zhu J, Cao H, Ren H, Fang X. miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Int J Oncol 2012;40:1553-60.
13. Meseguer S, Mudduluru G, Escamilla JM, Allgayer H, Barettino D. Micro-RNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF). J Biol Chem 2011;286:4150-64.
14. Pagliuca A, Valvo C, Fabrizi E, di MS, Biffoni M, Runci D, et al. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene 2013;32:4806-13.
15. Wang B, Wang H, Yang Z. MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. PLoS ONE 2012; 7:e47053.
16. Brabletz S, Bajdak K, Meidhof S, Burk U, Niedermann G, Firat E, et al. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells. EMBO J 2011;30:770-82.
17. Behrens J. Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 1999;18:15-30.
18. Meyer T, Hart IR. Mechanisms of tumour metastasis. Eur J Cancer 1998;34:214-21.
19. Sleeman JP, Thiery JP. SnapShot: the epithelial-mesenchymal transition. Cell 2011;145:162.
20. Thiery JP, Chopin D. Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 1999;18:31-42.
21. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. Cadherin switching. J Cell Sci 2008;121:727-35.
22. Comijn J, Berx G, Vermassen P, Verschueren K, van GL, Bruyneel E, et al. The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001;7:1267-78.
23. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601.
24. Cho HS, Kelly JD, Hayami S, Toyokawa G, Takawa M, Yoshimatsu M, et al. Enhanced expression of EHMT2 is involved in the proliferation of cancer cells through negative regulation of SIAH1. Neoplasia 2011; 13:676-84.
25. Duns G, van den Berg E, van DI, Osinga J, Hollema H, Hofstra RM, et al. Histone methyltransferase gene SETD2isanovel tumor suppressor gene in clear cell renal cell carcinoma. Cancer Res 2010;70:4287-91.
26. Newbold RF, Mokbel K. Evidence for a tumour suppressor function of SETD2 in human breast cancer: a new hypothesis. Anticancer Res 2010; 30:3309-11.
27. Scott KL, Plon SE. CHES1/FOXN3 interacts with Ski-interacting protein and acts as a transcriptional repressor. Gene 2005;359:119-26.
28. Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis 2010;27:83-90.
29. Ki DH, Jeung HC, Park CH, Kang SH, Lee GY, Lee WS, et al. Whole genome analysis for liver metastasis gene signatures in colorectal cancer. Int JCancer 2007;121:2005-12.
30. Pecot CV, Rupaimoole R, Yang D, Akbani R, Ivan C, Lu C, et al. Tumour angiogenesis regulation by the miR-200 family. Nat Commun 2013; 4:2427.
31. Arigoni M, Barutello G, Riccardo F, Ercole E, Cantarella D, Orso F, et al. miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2. Am J Pathol 2013;182: 2058-70.
32. Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, et al. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 2008;14:1340-8.
33. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell 2009;35:856-67.
34. Lin CW, Chang YL, Chang YC, Lin JC, Chen CC, Pan SH, et al. MicroRNA-135b promotes lung cancer metastasis by regulating multiple targets in the Hippo pathway and LZTS1. Nat Commun 2013;4:1877.
35. Rothe F, Ignatiadis M, Chaboteaux C, Haibe-Kains B, Kheddoumi N, Majjaj S, et al. Global microRNA expression profiling identifies MiR-210 associated with tumor proliferation, invasion and poor clinical outcomeinbreast cancer. PLoS ONE 2011;6:e20980.
36. Samaan G, Yugo D, Rajagopalan S, Wall J, Donnell R, Goldowitz D, et al. Foxn3 is essential for craniofacial development in mice and a putative candidate involved in human congenital craniofacial defects. Biochem Biophys Res Commun 2010;400:60-5.
37. Schuff M, Rossner A, Wacker SA, Donow C, Gessert S, Knochel W. FoxN3 is required for craniofacial and eye development of Xenopus laevis. Dev Dyn 2007;236:226-39.